Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Bone
|
December 27, 2006
Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation
Latifa Bakiri, Yasunari Takada, Martin Radolf, et al.
Cell
|
January 30, 2003
Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53
Robert Eferl, Romeo Ricci, Lukas Kenner, et al.
Genes & Development
|
August 17, 2006
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Ewa Stepniak, Romeo Ricci, Robert Eferl, et al.
Developmental Cell
|
June 7, 2003
c-Jun regulates eyelid closure and skin tumor development through EGFR signaling
Rainer Zenz, Harald Scheuch, Paul Martin, et al.
The EMBO Journal
|
July 2, 2004
The Fos-related antigen Fra-1 is an activator of bone matrix formation
Robert Eferl, Astrid Hoebertz, Arndt F Schilling, et al.
Arthritis Research & Therapy
|
January 30, 2008
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
Rainer Zenz, Robert Eferl, Clemens Scheinecker, et al.
Scientific Reports
|
November 18, 2016
Generation of metastatic melanoma specific antibodies by affinity purification
Birgit Schütz, Anita Koppensteiner, David Schörghofer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2008
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
Robert Eferl, Peter Hasselblatt, Martina Rath, et al.
Nature
|
September 16, 2005
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
Rainer Zenz, Robert Eferl, Lukas Kenner, et al.
Carcinogenesis
|
May 29, 2003
Induction of DNA synthesis in primary mouse hepatocytes is associated with nuclear pro-transforming growth factor alpha and erbb-1 and is independent of c-jun
Elisabeth Schausberger, Robert Eferl, Wolfram Parzefall, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Bone
|
December 27, 2006
Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation
Latifa Bakiri, Yasunari Takada, Martin Radolf, et al.
Cell
|
January 30, 2003
Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53
Robert Eferl, Romeo Ricci, Lukas Kenner, et al.
Genes & Development
|
August 17, 2006
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Ewa Stepniak, Romeo Ricci, Robert Eferl, et al.
Developmental Cell
|
June 7, 2003
c-Jun regulates eyelid closure and skin tumor development through EGFR signaling
Rainer Zenz, Harald Scheuch, Paul Martin, et al.
The EMBO Journal
|
July 2, 2004
The Fos-related antigen Fra-1 is an activator of bone matrix formation
Robert Eferl, Astrid Hoebertz, Arndt F Schilling, et al.
Arthritis Research & Therapy
|
January 30, 2008
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
Rainer Zenz, Robert Eferl, Clemens Scheinecker, et al.
Scientific Reports
|
November 18, 2016
Generation of metastatic melanoma specific antibodies by affinity purification
Birgit Schütz, Anita Koppensteiner, David Schörghofer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2008
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
Robert Eferl, Peter Hasselblatt, Martina Rath, et al.
Nature
|
September 16, 2005
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
Rainer Zenz, Robert Eferl, Lukas Kenner, et al.
Carcinogenesis
|
May 29, 2003
Induction of DNA synthesis in primary mouse hepatocytes is associated with nuclear pro-transforming growth factor alpha and erbb-1 and is independent of c-jun
Elisabeth Schausberger, Robert Eferl, Wolfram Parzefall, et al.
Page
of 8